3629 results for «2280»

Filter By

3629 results

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options

21 Nov 2021 – From PCR London Valves 2021

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

From TAVI to mitral and

Unusual situations during TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to benefit from the experience of our speakers and discover, among others, ECMO assistance during TAVI in high-risk patient with recent COVID-19 pneumonia, bailout "balloon trapping technic" to facilitate crossing the aortic valve during TAVI, or how to manage residual...

Unusual situations during TAVI

New evidence in the treatment of calcified lesions

19 May 2026 – From EuroPCR 2026

This session presents the latest evidence on treating calcified coronary lesions, comparing intravascular lithotripsy, cutting balloons, rotational and orbital atherectomy. It includes clinical trial data on efficacy, safety, and impact on coronary microvascular function, providing a robust foundation for evidence-based decision-making in calcified lesion management.

New evidence in the treatment of calcified lesions

TAVI procedural complications - Part 1: VSD, valve embolisation, and more

19 May 2026 – From EuroPCR 2026

This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.

TAVI procedural complications - Part 1: VSD, valve embolisation, and more

Effective strategies for preventing and resolving complications of PCI in STEMI or left main patients: a case-based educational session

19 May 2026 – From EuroPCR 2026

This case-based educational session focuses on the prevention and resolution of PCI complications in STEMI and left main patients. It offers a cross-geographic perspective on prompt recognition, risk evaluation, and diverse management techniques to improve patient outcomes in high-risk PCI scenarios.

How to prevent and manage complex and complicated LAA closure cases?

19 May 2026 – From EuroPCR 2026

Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.

How to prevent and manage complex and complicated LAA closure cases?

From data to decisions: calm and structured approaches to high pressure PCI

19 May 2026 – From EuroPCR 2026

Addressing high-pressure scenarios in the cath lab, this session explores calm and structured decision-making approaches for unusual and challenging PCI cases. It emphasizes optimizing management of life-threatening complications through real-time strategies and illustrative case discussions.

How should I treat a patient with a calcified mitral anatomy?

19 May 2026 – From EuroPCR 2026

This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.

How should I treat a patient with a calcified mitral anatomy?

Angiography-based physiology in clinical practice

19 May 2026 – From EuroPCR 2026

Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.

Managing difficult TAVI scenarios

19 May 2026 – From EuroPCR 2026

Focused on complex TAVI cases, this session reviews guideline recommendations for TAVI in younger patients, strategies for managing concomitant coronary artery disease, and considerations for treating asymptomatic severe aortic stenosis. Real-world cases illustrate clinical decision-making and outcomes.

Managing difficult TAVI scenarios

Optimal management of primary PCI complications

19 May 2026 – From EuroPCR 2026

This session delves into the optimal management of complications arising during primary PCI. It addresses critical scenarios from initial hesitation and unexpected challenges to confident treatment strategies for vessel complications. Notably, it explores complex cases such as paradoxical embolisation following rescue PCI in STEMI patients, providing...

Improving interventional care and occupational safety

19 May 2026 – From EuroPCR 2026

This session addresses advancements in interventional cardiology care quality and occupational safety. Key topics include patient-centered care perspectives, optimized catheterization lab scheduling, the impact of procedural volumes on outcomes, and innovations in radiation protection technologies.

Risk stratification and drug therapies in coronary arteries interventions

19 May 2026 – From EuroPCR 2026

This session offers a detailed examination of risk stratification and pharmacologic therapies in coronary artery interventions. It features innovative markers such as left ventricle filling pressure (E/E' ratio) for predicting myocardial injury, clinical outcome impacts in dialysis-dependent patients, intraoperative DOAC removal during CABG, and machine learning...

Beyond valves: expanding the structural toolbox

19 May 2026 – From EuroPCR 2026

This session expands the scope of structural heart interventions beyond valve therapies. It covers embolic protection in high-risk intracardiac procedures, outcomes of paravalvular leak closures, novel aortic root stent-graft research, cerebral ischemia predictors after TEVAR, and transcatheter ASD closure techniques.

High-risk PCI: how to optimise the result

19 May 2026 – From EuroPCR 2026

Focused on high-risk PCI, this session presents strategies to optimize procedural outcomes in complex cases. Discussions include contemporary approaches to challenging coronary anatomy, the role of balloon aortic valvuloplasty as a bridge to Impella-supported interventions, advanced mechanical support and thrombectomy in cardiogenic shock related to left...

Choosing the right tool to treat calcified bifurcation

19 May 2026 – From EuroPCR 2026

This session provides expert guidance on managing calcified bifurcation lesions. It highlights identification of high-risk scenarios, the role of coronary CT angiography and intravascular imaging in tool selection, and specialized techniques for treating calcified nodules in the left main coronary artery.

Choosing the right tool to treat calcified bifurcation

Outcomes in tricuspid valve intervention

19 May 2026 – From EuroPCR 2026

This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.

Outcomes in tricuspid valve intervention

The thin line between success and failure in MedTech start ups - Lessons learnt

18 May 2026 – From EuroPCR 2026

This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.

Addressing complications in calcified lesions

19 May 2026 – From EuroPCR 2026

This session delves into the complexities and management strategies for complications arising in calcified coronary lesions. Topics include advanced techniques such as puncturing the seal, handling lethal complications on calcified vessels, managing rare rotational atherectomy wire fractures, addressing massive stent deformation due to jailed rotawires, innovative...

Addressing complications in calcified lesions
Didn’t find what you were looking for?